Business

Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)

Growth of Dream Water® US and Canada by 8% compared to same quarter last year Growth of D...

articleDelivra Health Brands IncNovember 10, 20255/company/delivra-health-brands-inc/news/delivra-health-brands-reports-financial-results-for-first-quarter-of-fiscal-2026-highlighting-continued-growth-of-dream-water-r-and-livrelieftm
Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)

About this update from Delivra Health Brands Inc

[{"type":"text","content":"Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)Growth of Dream Water® US and Canada by 8% compared to same quarter last yearGrowth of Dream Water® E-commerce by 74% compared to same quarter last yearGrowth of LivRelief™ by 9% compared to same quarter last yearGrowth of LivRelief™ E-commerce by 16% compared to same quarter last yearVancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (\"Delivra Health\" or the \"Company\"), a consumer packaged goods company in the health and wellness sector, is pleased to announce its financial and operating results for the three months ended September 30, 2025 (\"Q1 2026\"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver relief from common health issues such as sleeplessness, chronic pain and anxiety.Management Commentary\"Our first quarter results reflect the continued strength of our core business, led by significant growth in Dream Water® sales across both Canadian and U.S. markets, as well as delivering strategic e-commerce performance for both Dream Water® and LivRelief™. These gains reinforce our strategy of building recurring consumer demand through innovation, marketing, and channel diversification. While we experienced a temporary reduction in our licensed LivRelief™ Infused business during its transition to a new licensed distribution partner, we remain confident this segment will return to growth in the second half of the fiscal year. Overall, Delivra Health continues to achieve its goals - growing revenues, maintaining positive Adjusted EBITDA(1), and strengthening the foundation for sustainable long-term performance,\" said Gord Davey, President and Chief Executive Officer of Delivra Health. \"In the second half of fiscal 2026, the Company will execute new launches with strategic customers that will add more depth and market coverage to the Company's existing portfolio of accounts, and this will accelerate our strategy of securing new retail partners and expanding Delivra Health Brands' customer base.\"Financial Highlights for the Three months Ended September 30, 2025(Expressed in thousands of Canadian doll...

More updates from Delivra Health Brands Inc